Education
About Us
Working with TipRanks
Follow Us
China Health Group Ltd (HK:0673)
:0673
0673 Stock Chart & Stats
HK$0.76
HK$0.03(9.09%)
At close: 4:00 PM EST
HK$0.76
HK$0.03(9.09%)
Day’s Range― - ―
52-Week RangeHK$0.11 - HK$0.86
Previous CloseN/A
Volume864.00K
Average Volume (3M)617.89K
Market Cap
HK$816.87M
Enterprise ValueHK$268.82M
Total Cash (Recent Filing)HK$1.05M
Total Debt (Recent Filing)HK$6.50M
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,339,138,200
10 Day Avg. Volume474,015
30 Day Avg. Volume617,889
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-14.98
Price to Sales (P/S)2.95
P/FCF Ratio-13.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Free Cash Flow GrowthReported improvement in free cash flow growth suggests the company may be beginning to convert operations into cash more effectively. If sustained, improving FCF can fund working capital, reduce reliance on external financing, and support strategic investments over the next 2–6 months.
Positive FCF-to-net Income RatioA positive free cash flow to net income ratio indicates cash generation is stronger than accounting losses imply. While partly driven by negative net income, a positive FCF metric points to some cash resilience that can help bridge operations and provide runway for restructuring or turnaround efforts.
Low Equity Volatility (Beta)A low beta indicates historically low share-price volatility relative to the market. For a company with financial stress, lower equity volatility can ease financing and planning, reduce refinancing risk, and provide management more predictable market conditions when executing longer-term recovery plans.
Bears Say
Negative Stockholders' EquityNegative shareholders' equity is a structural solvency red flag that impairs access to new equity and debt financing, increases risk of covenant breaches, and limits strategic flexibility. Over months this undermines ability to invest, withstand shocks, or execute turnarounds without external recapitalization.
Negative Operating And Free Cash FlowsPersistently negative operating and free cash flows create ongoing liquidity pressure, forcing dependence on financing or asset sales. This constrains capital spending, supplier relations, and growth initiatives, and raises the likelihood of solvency interventions within a multi-month horizon if trends persist.
Declining Revenue & Negative ProfitabilitySustained revenue declines and deeply negative margins signal structural demand, pricing, or cost-competitiveness problems. Without reversing revenue trends or materially improving margins, the business model struggles to generate sustainable profits, limiting long-term viability absent strategic change.
China Health Group News
0673 FAQ
What was China Health Group Ltd’s price range in the past 12 months?
China Health Group Ltd lowest stock price was HK$0.11 and its highest was HK$0.86 in the past 12 months.
What is China Health Group Ltd’s market cap?
China Health Group Ltd’s market cap is HK$816.87M.
When is China Health Group Ltd’s upcoming earnings report date?
China Health Group Ltd’s upcoming earnings report date is Jun 25, 2026 which is in 123 days.
How were China Health Group Ltd’s earnings last quarter?
China Health Group Ltd released its earnings results on Nov 28, 2025. The company reported -HK$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.021.
Is China Health Group Ltd overvalued?
According to Wall Street analysts China Health Group Ltd’s price is currently Overvalued.
Does China Health Group Ltd pay dividends?
China Health Group Ltd does not currently pay dividends.
What is China Health Group Ltd’s EPS estimate?
China Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Ltd have?
China Health Group Ltd has 1,339,138,200 shares outstanding.
What happened to China Health Group Ltd’s price movement after its last earnings report?
China Health Group Ltd reported an EPS of -HK$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Health Group Ltd?
Currently, no hedge funds are holding shares in HK:0673
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.70%
12-Months-Change
Fundamentals
Return on Equity
-465.55%
Trailing 12-Months
Asset Growth
-23.38%
Trailing 12-Months
Company Description
China Health Group Ltd
China Health Group (0673) is a healthcare-focused company operating primarily in China. The company is engaged in various sectors including pharmaceuticals, health supplements, and medical services. It aims to improve health outcomes through the provision of high-quality healthcare products and services, catering to the growing demand for health solutions in the region.
Technical Analysis
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
ClouDr Group Limited
―
IVD Medical Holding Limited
―
Charmacy Pharmaceutical Co., Ltd. Class H
―